Antimicrobial resistance in Campylobacter coli and Campylobacter jejuni in cynomolgus monkeys (Macaca fascicularis) and eradication regimens

被引:10
|
作者
Koga, Tetsufumi [1 ]
Aoki, Wataru [2 ]
Mizuno, Takashi [2 ]
Wakazono, Kuniko [2 ]
Ohno, Junki [2 ]
Nakai, Tsunehiro [2 ]
Nomiya, Takao [2 ]
Fujii, Miki [2 ]
Fusegawa, Keiichi [1 ]
Kinoshita, Kazuya [1 ]
Hamada, Takakazu [1 ]
Ikeda, Yoshinori [2 ]
机构
[1] Daiichi Sankyo Co Ltd, Biol Res Lab, Tokyo, Japan
[2] KAC Co Ltd, Tokyo, Japan
关键词
antimicrobial resistance; Campylobacter spp. cynomolgus monkey; eradication; MOLECULAR EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; SPP; ERYTHROMYCIN; SALMONELLA; PREVALENCE; INFECTION; ENTERITIS;
D O I
10.1016/j.jmii.2014.12.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Campylobacter spp. are zoonotic pathogens, however, knowledge about their presence and antimicrobial resistance in nonhuman primates is limited. Our animal facility purchased cynomolgus monkeys (Macaca fascicularis) from various Asian countries: China, Cambodia, Indonesia, the Philippines, and Vietnam. Methods: Colonization by Campylobacter spp. was investigated in 238 of the monkeys from 2009 to 2012 and antimicrobial susceptibility testing was carried out for these isolates. Furthermore, we eradicated these pathogens from these monkeys. Results: Campylobacter spp. were isolated from 47 monkeys from three specific countries: China, Cambodia, and Indonesia, with respective isolation rates of 15%, 36%, and 67%. Two monkeys, which were each infected with Campylobacter jejuni and Campylobacter coli, showed clinical symptoms of diarrhea and bloody feces. In total, 41 isolates of C. coli and 17 isolates of C. jejuni were detected. Antimicrobial susceptibility varied: in the monkeys from China, erythromycin (ERY)-, tetracycline (TET)-, and ciprofloxacin-resistant C. coli, in the monkeys from Cambodia, amoxicillin-intermediate, TET- and ciprofloxacin-resistant C. coli and amoxicillin- and ciprofloxacin-resistant C. jejuni, and in the monkeys from Indonesia, ciprofloxacin-resistant C. coli and TET- and ciprofloxacin-resistant C. jejuni were common (> 75%). Multiresistant isolates of C. coli were found in monkeys from all countries and multiresistant isolates of C. jejuni were found in monkeys from Indonesia. The eradication rate with azithromycin was comparable to that with gentamicin (GEN) by oral administration, and was higher than those with amoxicillin-clavulanic acid (AMC) and chloramphenicol (CHL). Conclusion: From the perspective of zoonosis, we should acknowledge multiresistant Campylobacter spp. isolated from the monkeys as a serious warning. Copyright (C) 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [41] QUINOLONE RESISTANCE IN CLINICAL STRAINS OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI
    HARNETT, N
    MCLEOD, S
    YONG, YA
    HEWITT, C
    VEARNCOMBE, M
    KRISHNAN, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (01) : 269 - 270
  • [42] Metronidazole Resistance of Campylobacter jejuni and Campylobacter coli from Different Animal Species
    Ica, Tuba
    Ciftci, Alper
    Savasan, Serap
    Diker, Kadir Serdar
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2009, 15 (04) : 629 - 632
  • [43] Fluoroquinolone Resistance Detection in Campylobacter coli and Campylobacter jejuni by Luminex® xMAP™ Technology
    Barco, Lisa
    Lettini, Antonia Anna
    Dalla Pozza, Maria Cristina
    Ramon, Elena
    Fasolato, Manuela
    Ricci, Antonia
    FOODBORNE PATHOGENS AND DISEASE, 2010, 7 (09) : 1039 - 1045
  • [44] Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients
    Sjogren, E
    Lindblom, GB
    Kaijser, B
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) : 257 - 261
  • [45] Antibiotic resistance in Campylobacter jejuni and Campylobacter coli isolated from food in Poland
    Mackiw, Elzbieta
    Korsak, Dorota
    Rzewuska, Katarzyna
    Tomczuk, Katarzyna
    Rozynek, Elzbieta
    FOOD CONTROL, 2012, 23 (02) : 297 - 301
  • [46] Ribosomal Mutations as the Main Cause of Macrolide Resistance in Campylobacter jejuni and Campylobacter coli
    Lehtopolku, Mirva
    Kotilainen, Pirkko
    Haanpera-Heikkinen, Marjo
    Nakari, Ulla-Maija
    Hanninen, Marja-Liisa
    Huovinen, Pentti
    Siitonen, Anja
    Eerola, Erkki
    Jalava, Jari
    Hakanen, Antti J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) : 5939 - 5941
  • [47] Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli
    Hanninen, Marja-Liisa
    Hannula, Minna
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1251 - 1257
  • [48] SURVEY OF PLASMIDS AND RESISTANCE FACTORS IN CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI
    TENOVER, FC
    WILLIAMS, S
    GORDON, KP
    NOLAN, C
    PLORDE, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (01) : 37 - 41
  • [49] Resistance to erythromycin of Campylobacter jejuni and Campylobacter coli isolated from animals and humans
    Tambur, Z.
    Miljkovic-Selimovic, B.
    Kulisic, Z.
    Mirkovic, D.
    Doder, R.
    Stanimirovic, Z.
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (03): : 342 - 346
  • [50] Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland
    Wardak, Sebastian
    Szych, Jolanta
    Zasada, Aleksandra Anna
    Gierezynski, Rafal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) : 1123 - 1125